Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 4, 2001, Pages 988-993

  Kupelian, Patrick A ^a,b   Reddy, Chandana A ^a   Klein, Eric A ^b   Willoughby, Twyla R ^a  

^a Department of Radiation Oncology ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Intensity modulation; Late toxicity; Local therapy; Prostatic neoplasms; Quality of life; Radiotherapy

Indexed keywords

HORMONES; PATIENT TREATMENT; TOXICITY; TUMORS; ULTRASONICS;

EXPANDED PROSTRATE CANCER INDEX COMPOSITE (ECIC);

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BLADDER DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM HEMORRHAGE; TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; ULTRASOUND;

AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RECTUM; URINARY BLADDER;

EID: 0035889347     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01730-8     Document Type: Article

References (18)

1. Toward optimal external-beam fractionation for prostate cancer
2. Fractionation and protraction for radiotherapy of prostate carcinoma
3. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy
4. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland
5. Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone
6. Higher than standard radiation doses (72 Gy or greater) with or without androgen deprivation in the treatment of localized prostate cancer
7. Conventional vs. conformal radiotherapy for prostate cancer; Preliminary results of dosimetry and acute toxicity
8. Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer
9. Daily transabdominal ultrasound localization of the prostate gland with the BAT system; 2705 alignments from 100 patients
10. Improvement in localization of prostate using a transabdominal ultrasound based system as assessed by implanted fiducial markers
11. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
12. Conformal radiotherapy for prostate cancer
13. Dose selection for prostate cancer patients based on dose comparison and dose response studies
14. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate
15. Prostate cancer treatment with radiotherapy; Maturing methods that minimize morbidity
16. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma
17. Short course intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) versus 3D-conformal radiotherapy (78 Gy at 2.0 Gy per fraction) for the treatment of localized prostate cancer; Comparable toxicity